Referencias
1. Sanín-Blair JE, Cuartas-Calle AM. Restricción del crecimiento intrauterino (RCIU) y el feto pequeño para la edad gestacional. En: Botero J, Jubiz A, Henao G, editores. Obstetricia y ginecología texto integrado. Octava edición. Bogotá: Québec World; 2008. p. 242-4.
2. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction – part 1. J Matern Fetal Neonatal Med. 2016;29(24):3977:87.
3. Departamento Administrativo Nacional de Estadística- DANE. Estadísticas Vitales Nacimientos y Defunciones. Reporte del 2014.
4. Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). 2013;26(3):222-5.
5. Raymond D, Peterson E. A critical review of early-onset and lateonset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
6. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol. 1993;169(5):1112-8.
7. Pimiento LM, Beltrán MA. Restricción del crecimiento intrauterino: una aproximación al diagnóstico, seguimiento y manejo. Rev Chil Obstet Ginecol. 2015;80(6):493-502.
8. Sehested LT, Pedersen P. Prognosis and risk factors for intrauterine growth retardation. Dan Med J. 2014;61(4):A4826.
9. Nardozza LM, Araujo Júnior E, Barbosa MM, Caetano AC, Lee DJ, Moron AF. Fetal growth restriction: current knowledge to the general Obs/Gyn. Arch Gynecol Obstet. 2012;286(1):1-13.
10. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391-403.
11. Figueras F, Gratacós E. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol. Fetal Diagn Ther. 2014;36(2):86-98.
12. Savchek S, Figueras F, Sanz Cortes M, Cruz Lemini M, Triunfo S, Botet F, et al. Evaluation of an optimal gestational age cut-off for the definition of early- and late- onset fetal growth restriction. Fetal Diagn Ther. 2014;36(2):99:105.
13. Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol. 2014;38(3):131-2.
14. Milosevic-Stevanovic J, Krstic M, Radovic-Janosevic D, Stefanovic M, Antic V, Djordjevic I. Preeclampsia with and without intrauterine growth restriction- Two pathogenetically different entities? Hypertens Pregnancy. 2016;35(4):573:82.
15. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started early in pregnancy: a metaanalysis. Obstet Gynecol. 2010;116(2):402-14.
16. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42(4):400-8
2. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction – part 1. J Matern Fetal Neonatal Med. 2016;29(24):3977:87.
3. Departamento Administrativo Nacional de Estadística- DANE. Estadísticas Vitales Nacimientos y Defunciones. Reporte del 2014.
4. Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). 2013;26(3):222-5.
5. Raymond D, Peterson E. A critical review of early-onset and lateonset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
6. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol. 1993;169(5):1112-8.
7. Pimiento LM, Beltrán MA. Restricción del crecimiento intrauterino: una aproximación al diagnóstico, seguimiento y manejo. Rev Chil Obstet Ginecol. 2015;80(6):493-502.
8. Sehested LT, Pedersen P. Prognosis and risk factors for intrauterine growth retardation. Dan Med J. 2014;61(4):A4826.
9. Nardozza LM, Araujo Júnior E, Barbosa MM, Caetano AC, Lee DJ, Moron AF. Fetal growth restriction: current knowledge to the general Obs/Gyn. Arch Gynecol Obstet. 2012;286(1):1-13.
10. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391-403.
11. Figueras F, Gratacós E. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol. Fetal Diagn Ther. 2014;36(2):86-98.
12. Savchek S, Figueras F, Sanz Cortes M, Cruz Lemini M, Triunfo S, Botet F, et al. Evaluation of an optimal gestational age cut-off for the definition of early- and late- onset fetal growth restriction. Fetal Diagn Ther. 2014;36(2):99:105.
13. Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol. 2014;38(3):131-2.
14. Milosevic-Stevanovic J, Krstic M, Radovic-Janosevic D, Stefanovic M, Antic V, Djordjevic I. Preeclampsia with and without intrauterine growth restriction- Two pathogenetically different entities? Hypertens Pregnancy. 2016;35(4):573:82.
15. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started early in pregnancy: a metaanalysis. Obstet Gynecol. 2010;116(2):402-14.
16. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42(4):400-8
Descargas
Los datos de descargas todavía no están disponibles.